The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in
Sponsorship statement:
Funding for the filming, production and publishing for this video was provided by A. Menarini Farmaceutica Internazionale SRL. Menarini has had no input into the video’s content or hosting.
MenariniLogo
17:27

BEACON series – Episode 1: Primary prevention of CVD – QRISK® <10%

BEACON series – Episode 1: Primary prevention of CVD – QRISK® <10%

1 September 2026

Supported

17:27
This interactive BEACON session explores the management of younger patients at high lifetime cardiovascular risk whose QRISK® scores may underestimate their true risk. The faculty will examine how to identify patients who would benefit from earlier intervention, interpret lifetime versus 10-year cardiovascular risk, and optimise lipid-lowering and cardiovascular risk reduction strategies in line with current evidence and guidelines.
Faculty

Chair
Professor Mike Cummings, Consultant Endocrinologist, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Speakers
Beverley Bostock, Advanced Nurse Practitioner, Mann Cottage Surgery, Gloucestershire
Dr Paul Downie, Consultant Chemical Pathologist, University Hospitals Bristol and Weston NHS Trust, Bristol
Dr Jim Moore, General Practitioner, Gloucestershire Care Services NHS Trust, Brockworth
Emily Turner, General Practice Pharmacist, Aire Valley Surgery and Guiseley and Yeadon Medical Practice, Leeds

Abbreviations

BEACON = Bringing Education and Awareness to Cholesterol Optimisation Needs; CVD = cardiovascular disease

Categories

Tags

Watch other episodes in the BEACON case study series

BEACON series – Episode 3: CVD risk management in type 2 diabetes

  • Beverley Bostock, Mike Cummings, Paul Downie, Jim Moore, Emily Turner

Supported

Funding for the filming, production and publishing for this video was provided by A. Menarini Farmaceutica Internazionale SRL. Menarini has had no input into the video's content or hosting.

BEACON series – Episode 4: Type 2 diabetes and chronic kidney disease

  • Beverley Bostock, Mike Cummings, Paul Downie, Jim Moore, Emily Turner

Supported

Funding for the filming, production and publishing for this video was provided by A. Menarini Farmaceutica Internazionale SRL. Menarini has had no input into the video's content or hosting.

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.